The influence of bile salts on the duration of action of the steroidal non-depolarizing neuromuscular blocking agent ORG 6368 was investigated in cats. The intravenous administration of ORG 6368 (100 ng/kg body wt) caused a maximum neuromuscular blockade of 71 +6% with a duration of action of 3.4 + 0.1 min. However, intraportal administration of the same dose caused no significant neuromuscular blockade. Following an infusion of dehydrocholate 320 [imol, lasting for 8 min, the magnitude and the duration of action of the neuromuscular blockade produced by ORG 6368 were increased markedly. This effect of the bile salt is possibly a result of inhibition of the hepatic uptake of ORG 6368, thereby retarding its disappearance from the plasma and consequently prolonging the neuromuscular blockade. The neuromuscular blocking effect of intraportally administered gallamine (1 mg/kg body wt) was not influenced significantly by the infusion of dehydrocholate.
dacuronium and ORG 6368 (2|3,16p-dipiperidino5a-androstan-3a-ol acetate dimethobromide) Agoston et al., 1977) . Therefore, alterations in hepatic function may influence the pharmacokinetics, and consequently the duration of action, of these drugs. It was reported that, in patients with cholestasis, the duration of action of pancuronium was prolonged (Somogyi, Shanks and Triggs, 1977) . Recently, Vonk and others (1978a, b) observed that bile salts inhibited the hepatocellular transport of the organic cations tubocurarine and acetylprocainamide ethobromide in intact rats, isolated perfused rat livers and isolated hepatocytes.
The aim of this study was to investigate the possible role of bile salts in the hepatic transport of neuromuscular blocking agents, which could lead to an increase in the duration of action of these compounds. The experiments were performed with ORG 6368 and gallamine triethiodide. ORG 6368 is a short-acting analogue of pancuronium bromide (Sugrue and Duff, 1973) . It has been shown (Agoston et al., 1977) that its duration of action is determined mainly by hepatic clearance. In contrast, the plasma disappearance of gallamine triethiodide, which is determined by renal function, theoretically should not be changed by alterations in the hepatic transport systems of drugs.
METHODS

Animal experiments
All experiments were carried out on adult cats (2-4 kg body wt) of either sex under pentobarbitone anaesthesia. After orotracheal intubation with a cuffed tube, mechanical ventilation with air was maintained at a rate of 30 b.p.m. with a tidal volume of 34 ml. In order to check the general condition of the cat, e.c.g. and mean arterial pressure were monitored. Mean arterial pressure was not less than 100 mg Hg in all experiments. Body temperature was kept constant at 37-38 °C by heating the operating table. To replace fluid loss, glucose 2.5% and saline 0.45% were infused through a polythene cannula via an external jugular vein. Neuromuscular studies (isometric twitch tension) were performed on the tibialis anterior muscle which was stimulated through its motor nerve with supramaximal square wave pulses of 0.2 ms duration at a frequency of 0.1 Hz. Following the administration of heparin 2500 i.u., a silicon catheter was placed in the hepatic portal vein to permit the administration of drugs into the portal system. After the administration of the neuromuscular blocking drugs, arterial blood samples were taken at the time when twitch tension approached 50% of control. Bolus injections of the neuromuscular blocking agents were made within periods of 5 s. The bile salts, dehydrocholate (Fluka A. G.) and chenodeoxycholate (Falk GmbH & Co) , were administered by continuous infusions through the catheter placed in the portal vein. In order to avoid accumulation, ORG 6368 (Organon Ltd) was administered at intervals of at least 30 min. Gallamine triethiodide (Flaxedil, Specia) was injected at intervals of 60 min.
Chemical analysis
ORG 6368 in plasma was estimated according to the procedures described before Agoston et al., 1977) .
Statistical analysis
Statistical comparisons were made using Student's t test with a 95% significance level. The values given are mean values + SEM.
RESULTS
The i.v. administration of ORG 6368 100 ng/kg body wt produced a maximal depression of the control twitch height to 71 ± 6% (n = 6) ( fig. 1A ; table I). The time to 90% recovery of control twitch tension was 3.4 + 0.1 min. When the same dose of ORG 6368 was administered through the catheter in the portal vein, a neuromuscular blockade of only 2 + 2% was produced ( fig. 1B ). The influence of bile salts was subsequently investigated. Dehydrocholate was infused at a rate of 40 [imol min" 1 over 8 min. The intraportal injection of ORG 6368 100 (xg/kg body wt immediately after the infusion of the bile salt resulted in 70 ±12% depression of twitch height and a duration to 90% recovery of 5.6 + 0.6 min ( fig. lc) . This potentiating effect of dehydrocholate was reversible and lasted from 30 min to approximately 180 min.
When an intraportal injection of ORG 6368 100 (xg/kg body wt was given, a neuromuscular blockade of 7 + 3% ( fig. ID) was subsequently produced, a pattern which was comparable to that before the administration of the bile salt. The i.v. administration of ORG 6368 caused approximately the same neuromuscular blockade as before the dehydrocholate administration (table 1:71 + 6%, lasting 4.0 + 1 min).
In contrast to the observations obtained with ORG 6368, the neuromuscular blocking effect of intraportally administered gallamine 1 mg/kg body wt was not influenced significantly by dehydrocholate infusion. Gallamine administered in this dose caused a 71 + 8% depression of twitch height with a duration to 90% recovery of 8.4 +1.0 min; after dehydrocholate infusion these values were 74 + 5% and 9.5 ±1.3 min respectively (n = 4).
The influence of dehydrocholate on the relationship between plasma concentration of ORG 6368 and the neuromuscular blocking effect is shown in table I. At 50% recovery of the twitch tension, the concentration of ORG 6368 was significantly higher in the presence of dehydrocholate.
DISCUSSION
The marked decrease in the effectiveness of ORG 6368 when injected into the portal vein, rather than into the general circulation, is explained by the high hepatic clearance of this drug (Agoston et al., 1977) . Differences in the patterns of efficacy of neuromuscular blocking agents injected by different routes have also been described by Hughes (1972) . In contrast to that of ORG 6368, gallamine's efficacy was not reduced when it was injected intraportally-an observation compatible with the absence of any important role of the liver in the plasma clearance of gallamine (Feldman, Cohen and Galling, 1969; Agoston et al., 1978) . During the infusion in the present study, and in separate in vitro experiments (unpublished data) in the rat phrenic nerve-diaphragm preparation, dehydrocholate (concentration up to 2.0 mmol) and chenodeoxycholate (concentration up to 0.2 mmol) did not influence the indirectly evoked twitch contractions.
The effects of the semi-synthetic bile salt dehydrocholate were studied in these experiments because this substance has previously been found to modify the hepatic transport of drugs (Vonk et al., 1978a, b) and, in the doses used, it is free from complicating cardiovascular actions. Its effects on the actions of neuromuscular blocking drugs were compared with, and found to be qualitatively similar to, those of the naturally occurring bile salt chenodeoxycholate.
Either bile salt, when infused into the portal vein, potentiated the neuromuscular blocking action of ORG 6368 injected by the same route. That the potentiating action was not the result of a peripheral sensitizing action of the bile salts at the neuromuscular junction was shown by the observation that gallamine was not similarly potentiated. Furthermore, the increased efficacy of intraportally injected ORG 6368 in the presence of bile salts was associated with an increased plasma concentration of the drug. Thus, it seems clear that the potentiating action of bile salts on ORG 6368 takes place in the liver, and occurs because the bile salts impair the net hepatic uptake of the neuromuscular blocking drug. The mechanism underlying this effect is not fully established. Inhibition of biliary excretion is unlikely, because biliary excretion of ORG 6368 in the cat is a relatively unimportant route of elimination (12% of the dose in 8 h; Agoston et al., 1977) .
The bile salts do not appear to displace ORG 6368 from the liver since, in unpublished experiments,.we have shown that after previous loading of the liver with ORG 6368, infusions of bile salts do not produce neuromuscular block. Therefore, we conclude that the bile salts act by inhibiting the primary hepatic uptake process of ORG 6368, a conclusion which is in agreement with earlier studies in which the interactions of bile salts with tubocurarine or acetylprocainamide ethobromide were studied (Vonk et al., 1978a, b) . The results suggest that in patients with an increased plasma concentration of bile salts, neuromuscular blocking agents that are cleared from the plasma by the liver may have an unusually prolonged duration of action.
PROLONGATION DE LA DUREE DE L'ACTION D'UN AGENT DE BLOCAGE NEUROMUSCULAIRE STEROIDE PAR LES SELS BILIAIRES
RESUME
On a fait des recherches sur des chats pour etudier l'influence des sels biliaires sur la duree de l'action de l'agent de blocage neuromusculaire steroide non depolarisant ORG 6368. L'administration intraveineuse d'ORG 6368 (a raison de 100 (ig/kg de poids du corps) a provoque un blocage neuromusculaire maximum de 71 + 6% avec une duree d'action de 3,4 + 0,1 mn. Cependant, l'administration intraportale de la meme dose n'a provoque aucun blocage neuromusculaire significatif. Apres l'infusion de 320 nmol de dehydrocholate, d'une duree de 8 mn, l'importance et la duree d'action du blocage musculaire produit par l'ORG 6368 ont ete distinctement et fortement accrues. Ces effets des sels biliaires sont probablement le resultat de l'inhibition de la fixation hepatique de l'ORG 6368, ce qui en a retarde la disparition du plasma et a par consequent prolonge le blocage neuromusculaire. L'effet de blocage neuromusculaire de la gallamine administree par voie intraportale (a raison de 1 mg/kg de poids du corps) n'a pas ete influence d'une maniere significative par l'infusion de dehydrocholate. 
SUMARIO
Se investigo en gatos la influencia de la sal biliar sobre las duraciones de accion del agente bloqueador neuromuscular no-depolarizante esteroidal ORG 6368. La administracion intravenosa de ORG 6368 (100 (ig/kg de peso corporal) causo un bloqueo neuromuscular maximo de 71 + 6%, con una duracion de accion de 3.4 ±0.1 min. Sin embargo, la administracion intraportal de la misma dosis no causo bloqueo neuromuscular significative Despues de una infusion de 320 (zmol de dehidrocolato, de 8 min de duracion, aumentaron notable y significantemente la magnitud y la duracion de accion del bloqueo neuromuscular producido por el ORG 6368. Posiblemente, este efecto de la sal biliar resulte de la inhibici6n de la captation hepatica de ORG 6368, demorando por causa de ello su disparici6n de la plasma y prolongando por ende el bloqueo neuromuscular. La infusion de dehidrocolato no innuendo de manera significativa el efecto bloqueador neuromuscular de la galamina administrada por via intraportal (1 mg/kg de peso corporal).
